SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mg1041@aol.com who wrote (203)11/12/1997 1:49:00 PM
From: men mailman  Read Replies (2) of 2068
 
I agree. OXHP is a great buy here with little risk and great upside. just spoke to company investor relations a few minutes back to verify a few points and went away feeling very good and just started my purchases of oxhp shares. a few points:

1) NO DEBT. clean balance sheet. show me another in this industry

2) $8 CASH per share

3) $14 book value per share

4) Volume and supply pressure has trickled down to ZILCH in last few days.

5) Business is excellent with very happy customer base.

6) analysts are still predicting $1.50- 2.00 eps for 98.

7) They will be expanding into new areas

8) Just received a report to money managers from fidelity written by s & p that raetes oxhp a 4 star buy as of 3 weeks ago with a stock price of $27. Many other analysts are starting to buy.

9) only 80 million shares great takeover potential.

10) volume is trickling down.

Of course there were computer problems however they were isolated and dealt with and will be behind us be it 1 qrtr or 2, or 4. But in a year there will be no trace of these problems and completely behind us. What will be left in 1 year is a healthy strong competitive force in the healthcare business.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext